Table 1.
Characteristics of the study participants (n = 46).
| Characteristic | Category | n | Mean (sd) or % |
|---|---|---|---|
| Age | All | 46 | 24.2 (8.2) |
| Sex | Males | 13 | 28.3 |
| Females | 33 | 71.7 | |
| Body mass index (kg/m2)^ | All | 46 | 22.5 (3.8) |
| < 25 kg/m2 | 40 | 87.0 | |
| ≥ 25 kg/m2 | 6 | 13.0 | |
| Racial Group | Asian | 26 | 56.5 |
| Caucasian | 10 | 21.7 | |
| South Asian or Pakistani | 4 | 8.7 | |
| Latin, Latino or Latino American | 3 | 6.5 | |
| Mixed race | 2 | 4.3 | |
| Black | 1 | 2.2 | |
| History of cardiovascular problems* | Yes | 2 | 4.3 |
| Regular medication use** | Yes | 10 | 21.7 |
| Past 24-h alcohol consumption (visit 1) *** | Yes | 5 | 11 |
| Past 24-h alcohol consumption (visit 2)^^ | Yes | 2 | 5 |
| Past 24-h caffeine consumption (visit 1) | Yes | 16 | 35 |
| Past 24-h caffeine consumption (visit 2)^^ | Yes | 15 | 37 |
| Time between visits (days) ^^ | All who completed both visits | 41 | 14.7 (6.8) |
^Body mass index (BMI) cutoff was chosen according to Canadian risk threshold guidelines defining BMI ≥ 25 kg/m2 as overweight or obese68. *High blood pressure (1 participant), history of heart flutters (1 participant). **Birth control (7 participants), Wellbutrin, Cymbalta/Wellbutrin/Abilify (2 participants), Claritin for allergies (1 participant). ***Not reported by 2 participants. ^^5 participants did not do the second visit. There was no reported environmental smoke exposure (if anyone has smoked inside the home or in their vicinity in the past 24 h).